1. |
Kim J, Tan Z, Lubman DM. Exosome enrichment of human serum using multiple cycles of centrifugation. Electrophoresis, 2015, 36(17): 2017-2026.
|
2. |
央茂, 李永盛, 吴文广, 等. 液态活检技术在胆道肿瘤诊治中的应用进展. 中华肝胆外科杂志, 2021, 27(6): 472-476.
|
3. |
Liu XQ, Tufman A, Kiefl R, et al. Identification of lung adenocarcinoma-specific exosome RNAs in peripheral blood by RNA-Seq analysis. Eur Rev Med Pharmacol Sci, 2020, 24(4): 1877-1886.
|
4. |
闵贝贝, 朱莉, 曾娟. 结直肠癌患者血浆外泌体中miRNA-23b的表达及其临床意义. 实用医学杂志, 2020, 36(7): 863-868.
|
5. |
李永盛, 王许安, 吴文广, 等. 外泌体在胆道恶性肿瘤诊治中应用进展. 中国实用外科杂志, 2021, 41(10): 1178-1180, 1185.
|
6. |
刘艳, 戴鹏, 朱运峰. 外泌体作为肿瘤标志物的研究进展. 中国生物工程杂志, 2019, 39(8): 74-79.
|
7. |
Macfarlane CL, Quek S, Pionnier N, et al. The insufficiency of circulating miRNA and DNA as diagnostic tools or as biomarkers of treatment efficacy for Onchocerca volvulus. Sci Rep, 2020, 10(1): 6672. doi: 10.1038/s41598-020-63249-4.
|
8. |
Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem, 2010, 56(11): 1733-1741.
|
9. |
Arbelaiz A, Azkargorta M, Krawczyk M, et al. Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Hepatology, 2017, 66(4): 1125-1143.
|
10. |
Nakaoka T, Saito Y, Saito H. Aberrant DNA methylation as a biomarker and a therapeutic target of cholangiocarcinoma. Int J Mol Sci, 2017, 18(6): 1111. doi: 10.3390/ijms18061111.
|
11. |
Correa-Gallego C, Maddalo D, Doussot A, et al. Circulating plasma levels of microRNA-21 and microRNA-221 are potential diagnostic markers for primary intrahepatic cholangiocarcinoma. PLoS One, 2016, 11(9): e0163699. doi: 10.1371/journal.pone.0163699.
|
12. |
Kishimoto T, Eguchi H, Nagano H, et al. Plasma miR-21 is a novel diagnostic biomarker for biliary tract cancer. Cancer Sci, 2013, 104(12): 1626-1631.
|
13. |
Liang H, Gong F, Zhang S, et al. The origin, function, and diagnostic potential of extracellular microRNAs in human body fluids. Wiley Interdiscip Rev RNA, 2014, 5(2): 285-300.
|
14. |
Dang XT, Zeng XR. Targeted therapeutic delivery using engineered exosomes and its applications in cardiovascular diseases. Gene, 2016, 575(2 Pt 2): 377-384.
|
15. |
Samandari M, Julia MG, Rice A, et al. Liquid biopsies for management of pancreatic cancer. Transl Res, 2018, 201: 98-127.
|
16. |
Li X, Wang Y, Wang Q, et al. Exosomes in cancer: small transporters with big functions. Cancer Lett, 2018, 435: 55-65.
|
17. |
Wang M, Yu F, Ding H, et al. Emerging function and clinical values of exosomal microRNAs in cancer. Mol Ther Nucleic Acids, 2019, 16: 791-804.
|
18. |
Joyce DP, Kerin MJ, Dwyer RM. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer. Int J Cancer, 2016, 139(7): 1443-1448.
|
19. |
Garcia-Romero N, Esteban-Rubio S, Rackov G, et al. Extracellular vesicles compartment in liquid biopsies: Clinical application. Mol Aspects Med, 2018, 60: 27-37.
|
20. |
Severino V, Dumonceau JM, Delhaye M, et al. Extracellular vesicles in bile as markers of malignant biliary stenoses. Gastroenterology, 2017, 153(2): 495-504.
|
21. |
Li L, Masica D, Ishida M, et al. Human bile contains microRNA-laden extracellular vesicles that can be used for cholangio-carcinoma diagnosis. Hepatology, 2014, 60(3): 896-907.
|
22. |
Li P, Kaslan M, Lee SH, et al. Progress in exosome isolation techniques. Theranostics, 2017, 7(3): 789-804.
|